Back
Protagonist Therapeutics Vs. Celanese Industry Stock Comparison
Sell
44
PTGX
Protagonist Therapeutics
Last Price:
47.60
Seasonality Move:
18.58%
Sell
18
CE
Celanese
Last Price:
92.40
Seasonality Move:
4.05%
Sell
44
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Celanese (CE)
is a Sell
Is Celanese a Buy, Sell or Hold?
- The current Celanese [CE] share price is $91.00. The Score for CE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $45.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 48.74 | Sell |
| Chaikin Money Flow: | 154951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.55 - 47.39) | Sell |
| Bollinger Bands (100): | (35.98 - 45.9) | Buy |
CE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.56 | Sell |
| Relative Strength Index (14 RSI): | 13.82 | Sell |
| Chaikin Money Flow: | -9795947 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.2 - 138.9) | Sell |
| Bollinger Bands (100): | (124.4 - 139.28) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.09 | Sell |
| 20-day SMA: | 46.37 | Sell |
| 50-day SMA: | 45.14 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 46.38 | Sell |
| 50-day EMA: | 44.64 | Buy |
| 200-day EMA: | 35.99 | Buy |
CE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.25 | Sell |
| 20-day SMA: | 128.76 | Sell |
| 50-day SMA: | 128.71 | Sell |
| 200-day SMA: | 143.3 | Sell |
| 8-day EMA: | 118.88 | Sell |
| 20-day EMA: | 125.73 | Sell |
| 50-day EMA: | 129.26 | Sell |
| 200-day EMA: | 136.01 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.
Celanese Earnings Growth & CE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $2.26 per share.
Protagonist Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celanese Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||